Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

A new multiprogrammable isotopic powered cardiac pacemaker.

N P Smyth, D L Purdy, D Sager

Pacing and Clinical Electrophysiology : PACE

|September 1, 1982

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Why case management remains essential.

The Case manager·2000

Same author

Juvenile rheumatoid arthritis and common variable hypogammaglobulinemia.

The Journal of rheumatology·1998

Same author

North American Society of Pacing and Electrophysiology policy statement. The NASPE/BPEG defibrillator code.

Pacing and clinical electrophysiology : PACE·1993

Same author

Esophageal rupture complicated by a gastrocardiac fistula: review of the literature and report of a successfully treated case.

The Annals of thoracic surgery·1989

Same author

Chlorambucil--an effective corticosteroid-sparing therapy for pyoderma gangrenosum.

Journal of the American Academy of Dermatology·1989

Same author

The NASPE/BPEG generic pacemaker code for antibradyarrhythmia and adaptive-rate pacing and antitachyarrhythmia devices.

Pacing and clinical electrophysiology : PACE·1987

Same journal

A Case of Permanent Pacemaker Implantation via the Epicardial Approach Using the 3830 Lead in an 11-Day-Old Neonate (With Follow-Up of the Above Case).

Pacing and clinical electrophysiology : PACE·2026

Same journal

Cryoballoon Versus Radiofrequency Ablation for Persistent Atrial Fibrillation: Meta-Analysis of Randomized Trials.

Pacing and clinical electrophysiology : PACE·2026

Same journal

Tilt Test Duration in Suspected Vasovagal Syncope: Temporal Patterns and Diagnostic Yield in Patients From Central China.

Pacing and clinical electrophysiology : PACE·2026

Same journal

Combined Leadless Pacing and Subcutaneous ICD Therapy in Long QT Syndromes.

Pacing and clinical electrophysiology : PACE·2026

Same journal

Association of Anesthesia Modality With Procedural Parameters and Clinical Outcomes in PVI for Atrial Fibrillation.

Pacing and clinical electrophysiology : PACE·2026

Same journal

Zero-Fluoroscopy Cryoballoon Ablation for Paroxysmal Atrial Fibrillation in a Patient With Dextrocardia: A Case Report.

Pacing and clinical electrophysiology : PACE·2026

See all related articles

New multiprogrammable, isotopic-powered cardiac pacemakers offer adjustable settings for improved patient outcomes. Adjusting programmable parameters proved beneficial in most cases, highlighting the importance of this feature for long-term device function.

Area of Science:

Cardiology
Biomedical Engineering
Nuclear Medicine

Background:

Cardiac pacemakers are essential for managing bradyarrhythmias.
Isotopic power sources offer extended longevity compared to traditional batteries.
Multiprogrammability allows for device parameter adjustments post-implantation.

Purpose of the Study:

To evaluate the clinical utility of a novel multiprogrammable, isotopic-powered cardiac pacemaker.
To assess the feasibility and benefits of adjusting programmable parameters in these devices.

Main Methods:

Implantation of a custom multiprogrammable, isotopic-powered cardiac pacemaker in six patients.
Post-implantation monitoring and parameter adjustment over a two-year study period.
Inclusion of both initial implants and one replacement device.

Related Experiment Videos

Main Results:

The device was successfully implanted in all six patients.
Programmable parameter adjustments were found advantageous in five out of six cases.
The multiprogrammability feature was crucial for optimizing device function over time.

Conclusions:

Multiprogrammable, isotopic-powered cardiac pacemakers are clinically viable.
The ability to adjust parameters is critical for maximizing the benefit of long-lived isotopic pacemakers.
Ongoing FDA-approved clinical trials will further validate these findings.